Sort
15,842 grants matching “pancreatic cancer”
Novel Inhibitors of Akt Signaling in Pancreatic Cancer
$415,914Garth Powis · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA
Targeting the cytokine circuitry of KRAS-driven lung cancer
$415,743David A Barbie · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Targeting the cytokine circuitry of KRAS-driven lung cancer
$415,743David A Barbie · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Acute radiation injury alters microRNA profiles that predict late tissue-specific damage
$415,703Dorthe Schaue · University Of California Los Angeles · U01 · FY2020 · AI
MECHANISMS OF SIGNAL TRANSDUCTION BY RAS PROTEINS
$415,692State University New York Stony Brook · R37 · FY2005 · CA
Neurogenic Amplification of Pancreatitis Pain
$415,513Karin N Westlund-High · University Of Kentucky · R01 · FY2013 · NS
Role of Neurogenic Inflammation in Pancreatic Cancer
$415,485Brian M Davis · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · CA
Clinical trial development in cancer vaccines
$415,410Samir Khleif · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Investigating Amino Acid Depletion in the Tumor Microenvironment as a Metabolic Immune Checkpoint
$415,283Craig B Thompson · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Mouse Models for Tumor Progression and Maintenance
$415,260Filippo G Giancotti · Sloan-Kettering Inst Can Research · P01 · FY2011 · CA
Role of type 2 immune response in pancreatic cancer tumorigenesis
$415,258Prasenjit Dey · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Mouse Models for Tumor Progression and Maintenance
$415,238Filippo G Giancotti · Sloan-Kettering Inst Can Research · P01 · FY2012 · CA
Project 1: Targeting autophagy for the treatment of KRAS-mutant PDAC
$415,212Channing J Der · Univ Of North Carolina Chapel Hill · P50 · FY2023 · CA
COMPREHENSIVE EVALUATION OF ALTERED SYSTEMIC METABOLISM AND PANCREATIC CANCER RISK
$415,200Dana-Farber Cancer Institute, Inc. · · FY2014 · Department of Defense
Mass Spectrometry Shared Resource
$415,139Darryl J Pappin · Cold Spring Harbor Laboratory · P30 · FY2022 · CA
Mass Spectrometry Shared Resource
$415,139Darryl J Pappin · Cold Spring Harbor Laboratory · P30 · FY2021 · CA
Mass Spectrometry Shared Resource
$415,139Darryl J Pappin · Cold Spring Harbor Laboratory · P30 · FY2025 · CA
Mass Spectrometry Shared Resource
$415,139Darryl J Pappin · Cold Spring Harbor Laboratory · P30 · FY2023 · CA
Project 3: Chronic interferon and bile acid signaling as drivers of immunosuppression in age-related liver cancer
$415,068Susan M Kaech · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2022 · AG
Project 3 â Stromal derived IL-6/STAT3 signaling in the development and progression of PDAC
$415,057Michael C Ostrowski · Medical University Of South Carolina · P01 · FY2022 · CA
Tumor maintenance and development in mouse models
$415,000Sloan-Kettering Institute For Cancer Res · U01 · FY2004 · CA
Novel Inhibitors of Akt Signaling in Pancreatic Cancer
$414,979Garth Powis · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA
Molecular Imaging Markers for Glutaminolysis in Breast Cancer
$414,966David A Mankoff · University Of Pennsylvania · R01 · FY2017 · CA
Project 2: Immune signals promoting pancreas cancer stemness and progression
$414,574Steven E Artandi · Stanford University · P01 · FY2022 · CA
Project 2: Immune signals promoting pancreas cancer stemness and progression
$414,571Steven E Artandi · Stanford University · P01 · FY2023 · CA